The Presence of SH2B3 mutations Identifies a Distinct Subtype of Myelodysplastic Neoplasms

被引：0

作者：

Montoro, Maria Julia ^{[1
]}

Acha, Pamela ^{[1
]}

Meggendorfer, Manja

Ali, Najla H. Al ^{[3
]}

Navarro, Victor ^{[4
]}

Pierce, Sherry ^{[5
]}

Bravo-Perez, Carlos

Migeon, Marie Adeline ^{[7
]}

Julia, Mestre ^{[8
]}

Metzeler, Klaus H. ^{[9
]}

Wulfert, Michael ^{[10
]}

Diaz-Beya, Marina ^{[11
]}

Betz, Beate ^{[12
]}

Clappier, Emmanuelle ^{[13
]}

Tormo, Mar ^{[14
]}

Pomares, Helena ^{[15
]}

Jerez, Andres

Del Rey, Monica ^{[16
]}

Saumell, Silvia ^{[17
]}

Barbero, Laura ^{[18
]}

Rivero, Maria Eugenia ^{[19
]}

Diez-Campelo, Maria ^{[19
,20
]}

Sallman, David ^{[21
]}

Ezponda, Teresa ^{[2
,22
]}

Chen, Weina ^{[23
]}

Xie, Zhuoer ^{[3
]}

Bosch, Francesc ^{[24
]}

Germing, Ulrich ^{[25
]}

Platzbecker, Uwe ^{[9
]}

Sole, Francesc ^{[26
]}

Fenaux, Pierre ^{[27
]}

Maciejewski, Jaroslaw ^{[6
]}

Garcia-Manero, Guillermo

Komrokji, Rami S.

Haferlach, Torsten ^{[2
]}

Valcarcel, David ^{[28
]}

机构：

[1] Vall DHebron Univ Hosp, Dept Hematol, Barcelona, Spain

[2] MLL Munich Leukemia Lab, Munich, Germany

[3] Univ S Florida, Moffitt Canc Ctr, Tampa, FL USA

[4] Hosp Univ Vall dHebron, Vall dHebron Inst Oncol VHIO, Oncol Data Sci ODysSey, Barcelona, Spain

[5] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA

[6] Cleveland Clin, Taussig Canc Inst, Dept Translat Hematol & Oncol Res, Cleveland, OH USA

[7] Hop St Louis, Serv Hematol, St Louis, France

[8] Inst Recerca Leucemia Josep Carreras, MDS Grp, Badalona, Spain

[9] Univ Leipzig Med Ctr, Dept Hematol Cellular Therapy, Leipzig, Germany

[10] Dusseldorf Univ Hosp, Dept Haematol Oncol & Clin Immunol, Dusseldorf, Germany

[11] Hosp Clin Barcelona, Hematol Dept, Barcelona, Spain

[12] Heinrich Heine Univ Dusseldorf, Inst Human Genet, Dusseldorf, Germany

[13] St Louis Hosp, Paris, France

[14] Hosp Clin Valencia, Dept Hematol, Valencia, Spain

[15] Hosp Duran & Reynals, ICO, ICO Hosp, IDIBELL, Barcelona, Spain

[16] Univ Hosp Salamanca, IBSAL, Salamanca, Spain

[17] Hosp Universitari Vall dHebron, Dept Hematol, Barcelona, Spain

[18] HOSP RAMON & CAJAL, Dept Hematol, MADRID, Spain

[19] Hosp Arnau Vilanova, Dept Cuidados intensivos, Lerida, Spain

[20] Univ Salamanca, Hosp Univ Salamanca, IBSAL, IBMCC,CSIC,Canc Res Ctr, Salamanca, Spain

[21] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA

[22] CIBERONC, Ctr Invest Biomed Red Canc, Madrid, Spain

[23] Southwestern Med Ctr, Dept Pathol, Dallas, TX USA

[24] Hosp Univ Vall dHebron, Hematol Dept, Barcelona, Spain

[25] Heinrich Heine Univ, Univ Med Ctr Dusseldorf, Med Fac, Dusseldorf, Germany

[26] Inst Recerca Josep Carreras, Myelodysplast Syndromes Res Grp, Badalona, Spain

[27] Paris 7 Univ, Hop Saint Louis, Hop St Louis, Paris, France

[28] Univ Hosp Vall dHebron, Vall dHebron Inst Oncol VHIO, Dept Hematol, Barcelona, Spain

来源：

BLOOD | 2024年 / 144卷

关键词：

D O I：

10.1182/blood-2024-194488

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3214 / 3217

页数：4

共 50 条

[1] SH2B3 Mutations Are Associated with Neutrophilia in Myeloproliferative neoplasms (MPN) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)
Zhang, Xi
Li, Peng
Ding, Yi
He, Rong
Zheng, Gang
LABORATORY INVESTIGATION, 2024, 104 (03) : S1525 - S1526
[2] Familial and Acquired SH2B3 mutations in ALL
Perez-Garcia, Arianne
LeDuc, Charles A.
Kelly, Kara A.
Jalas, Chaim
Chung, Wendy K.
Ferrando, Adolfo A.
BLOOD, 2012, 120 (21)
[3] SH2B3 Mutations in Patients with JAK2-Negative Erythrocytosis
M'Hiri, Iman
Chin-Yee, Benjamin
Bhai, Pratibha
Wang, Andrea
Ho, Jenny
Lazo-Langner, Alejandro
Levy, Michael
Schenkel, Laila
Hedley, Benjamin
Chin-Yee, Ian
Sadikovic, Bekim
Hsia, Cyrus
BLOOD, 2023, 142
[4] Null-type SH2B3 mutations are potential drivers in a subset of Ph-negative myeloproliferative neoplasms
Zhang, Xi
Ding, Yi
Li, Peng
Bourgeois, Kirk
Rangan, Aruna
Herrick, Jennifer L.
Pardanani, Animesh
Chen, Dong
Viswanatha, David
He, Rong
Zheng, Gang
AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (09) : 1841 - 1844
[5] The function of SH2B3 (LNK) in the kidney
Blass, Gregory
Mattson, David L.
Staruschenko, Alexander
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2016, 311 (04) : F682 - F685
[6] The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders
Maslah, N.
Cassinat, B.
Verger, E.
Kiladjian, J-J
Velazquez, L.
LEUKEMIA, 2017, 31 (08) : 1661 - 1670
[7] A novel start-loss mutation of the SH2B3 gene in a family with myeloproliferative neoplasms
Beghini, Alessandro
Leuzzi, Livia
Abazari, Nazanin
Bossi, Luca E.
Guido, Valentina
Trojani, Alessandra
Cairoli, Roberto
HEMATOLOGICAL ONCOLOGY, 2022, 40 (05) : 1109 - 1112
[8] Comparative analysis of the SH2B3/LNK gene in mammals: A key to understanding myeloproliferative neoplasms
Adebanjo, Adewunmi
Zhao, Z. Joe
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
[9] The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders
N Maslah
B Cassinat
E Verger
J-J Kiladjian
L Velazquez
Leukemia, 2017, 31 : 1661 - 1670
[10] LNK/SH2B3 Loss Exacerbates the Development of Myeloproliferative Neoplasms in CBL-deficient Mice
Chen, Yafei
Gong, Shangyu
Tang, Juan
Wang, Xinying
Gao, Yudan
Yang, Hanying
Chen, Wanze
Hu, Hailiang
Tong, Wei
Lv, Kaosheng
STEM CELL REVIEWS AND REPORTS, 2025, 21 (02) : 509 - 519

← 1 2 3 4 5 →